TR199800406T1 - Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�. - Google Patents

Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�.

Info

Publication number
TR199800406T1
TR199800406T1 TR1998/00406T TR9800406T TR199800406T1 TR 199800406 T1 TR199800406 T1 TR 199800406T1 TR 1998/00406 T TR1998/00406 T TR 1998/00406T TR 9800406 T TR9800406 T TR 9800406T TR 199800406 T1 TR199800406 T1 TR 199800406T1
Authority
TR
Turkey
Prior art keywords
lmas
pct
zeylerinin
tienotriazolodiazepinin
kullan
Prior art date
Application number
TR1998/00406T
Other languages
English (en)
Turkish (tr)
Inventor
Kempen Herman
Original Assignee
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F.Hoffmann-La Roche Ag filed Critical F.Hoffmann-La Roche Ag
Publication of TR199800406T1 publication Critical patent/TR199800406T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
TR1998/00406T 1995-09-09 1996-08-30 Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�. TR199800406T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP95114163 1995-09-09

Publications (1)

Publication Number Publication Date
TR199800406T1 true TR199800406T1 (en) 1998-05-21

Family

ID=8219597

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1998/00406T TR199800406T1 (en) 1995-09-09 1996-08-30 Alipoprotein A-I d�zeylerinin artt�r�lmas� i�in bir tienotriazolodiazepinin kullan�lmas�.

Country Status (14)

Country Link
US (1) US5854238A (2)
EP (1) EP0853480B1 (2)
JP (1) JPH11512107A (2)
KR (1) KR19990044460A (2)
CN (1) CN1101680C (2)
AT (1) ATE230600T1 (2)
AU (1) AU725249B2 (2)
BR (1) BR9610390A (2)
CA (1) CA2230477A1 (2)
DE (1) DE69625696T2 (2)
DK (1) DK0853480T3 (2)
ES (1) ES2188783T3 (2)
TR (1) TR199800406T1 (2)
WO (1) WO1997009048A1 (2)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518412B1 (en) * 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) * 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6253569B1 (en) * 1999-05-07 2001-07-03 James J. Hall Portable storage unit for game animals
US7723303B2 (en) * 2000-08-24 2010-05-25 The Regents Of The University Of California Peptides and peptide mimetics to treat pathologies characterized by an inflammatory response
US7148197B2 (en) * 2000-08-24 2006-12-12 The Regents Of The University Of California Orally administered small peptides synergize statin activity
US7166578B2 (en) 2000-08-24 2007-01-23 The Regents Of The University Of California Orally administered peptides synergize statin activity
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US8568766B2 (en) 2000-08-24 2013-10-29 Gattadahalli M. Anantharamaiah Peptides and peptide mimetics to treat pathologies associated with eye disease
US7199102B2 (en) * 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US7144862B2 (en) 2000-08-24 2006-12-05 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US7429593B2 (en) 2001-09-14 2008-09-30 Shionogi & Co., Ltd. Utilities of amide compounds
US20040235877A1 (en) 2001-09-14 2004-11-25 Natsuki Ishizuka Novel use of tricyclic compound
US8124625B2 (en) 2001-09-14 2012-02-28 Shionogi & Co., Ltd. Method of enhancing the expression of apolipoprotein AI using olefin derivatives
US6930085B2 (en) * 2002-04-05 2005-08-16 The Regents Of The University Of California G-type peptides to ameliorate atherosclerosis
US7579319B2 (en) 2004-12-06 2009-08-25 The Regents Of The University Of California Methods for improving the structure and function of arterioles
US8557767B2 (en) 2007-08-28 2013-10-15 Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
EP2195331B1 (en) 2007-08-28 2013-11-20 Uab Research Foundation Synthetic apolipoprotein e mimicking polypeptides and methods of use
EA018620B1 (ru) * 2008-10-30 2013-09-30 Сёркомед Ллк ПРОИЗВОДНЫЕ ТИЕНОТРИАЗОЛОДИАЗЕПИНА, АКТИВНЫЕ В ОТНОШЕНИИ Apo A1
MX384074B (es) 2010-05-14 2025-03-12 Dana Farber Cancer Inst Inc Composiciones y métodos para tratar neoplasias, enfermedades inflamatorias y otros trastornos.
MX373121B (es) 2010-05-14 2020-04-30 Dana Farber Cancer Inst Inc Composiciones y metodos para el tratamiento de leucemia.
US9301962B2 (en) 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
JP5913292B2 (ja) * 2010-05-14 2016-04-27 ダナ−ファーバー キャンサー インスティテュート， インコーポレイテッド 代謝を調節する組成物および方法
WO2015013635A2 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
EP3066101B1 (en) 2013-11-08 2020-07-29 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
EP3099677A4 (en) 2014-01-31 2017-07-26 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
WO2015117087A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
KR20160130778A (ko) 2014-02-28 2016-11-14 텐샤 세러퓨틱스 인코포레이티드 고인슐린혈증과 관련된 질환의 치료
CA2954475C (en) 2014-07-31 2023-05-16 Uab Research Foundation Apoe mimetic peptides and higher potency to clear plasma cholesterol
EP3177626A4 (en) 2014-08-08 2017-12-27 Dana Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
MX2017001757A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de dihidropteridinona y sus usos.
AU2015339511B2 (en) 2014-10-27 2020-05-14 Tensha Therapeutics, Inc. Bromodomain inhibitors
EP3307728A4 (en) 2015-06-12 2019-07-17 Dana Farber Cancer Institute, Inc. COMBINATION THERAPY OF TRANSCRIPTION INHIBITORS AND CHINESE INHIBITORS
PE20181287A1 (es) 2015-09-11 2018-08-07 Dana Farber Cancer Inst Inc Ciano tienotriazolpirazinas y usos de las mismas
UA123946C2 (uk) 2015-09-11 2021-06-30 Дана-Фарбер Кенсер Інстітьют, Інк. Ацетамідтієнотриазолодіазепіни й шляхи їх застосування
CA3003288A1 (en) 2015-11-25 2017-06-01 Dana-Farber Cancer Institute, Inc. Bivalent bromodomain inhibitors and uses thereof
MX2020013608A (es) 2018-06-13 2021-03-09 Worg Pharmaceuticals Hangzhou Co Ltd Preparacion de derivados de triazepina condensados y su uso como inhibidores de bet.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH12303A (en) * 1973-02-08 1979-01-16 Hoffmann La Roche Thienotriazolodiazepine derivatives
US4155913A (en) * 1973-02-08 1979-05-22 Hoffmann-La Roche Inc. Thienotriazolodiazepine derivatives
JPS50100096A (2) * 1974-01-08 1975-08-08

Also Published As

Publication number Publication date
EP0853480B1 (en) 2003-01-08
KR19990044460A (ko) 1999-06-25
DE69625696D1 (de) 2003-02-13
ATE230600T1 (de) 2003-01-15
AU725249B2 (en) 2000-10-12
BR9610390A (pt) 1999-07-06
CN1195989A (zh) 1998-10-14
ES2188783T3 (es) 2003-07-01
AU6930396A (en) 1997-03-27
DE69625696T2 (de) 2003-10-16
JPH11512107A (ja) 1999-10-19
DK0853480T3 (da) 2003-05-05
CN1101680C (zh) 2003-02-19
EP0853480A1 (en) 1998-07-22
MX9801753A (es) 1998-08-30
US5854238A (en) 1998-12-29
WO1997009048A1 (en) 1997-03-13
CA2230477A1 (en) 1997-03-13

Similar Documents

Publication Publication Date Title
ATE230600T1 (de) Verwendung eines thienotriazoldiazepins zur erhöhung des apolopoproteins a-i niveaus
IL124674A0 (en) Piperazine derivatives pharmaceutical compositions containing the same and use thereof
CA2174494A1 (en) Benzofurans
NZ290420A (en) Phenyl or pyridyl-amide substituted dihydro benzofurans; medicaments
BR9710994A (pt) Derivados anticonvulsivos úteis no tratamento de obesidade.
BG103190A (en) Substituted pyrimidine derivatives and their pharmaceutical application
IL143748A0 (en) Substituted aryl or heteroarylamides having retinoid-like biological activity
CY2476B1 (en) Benzonaphthyridines as bronchial therapeutics.
AU6617596A (en) Cyclo-oxygenase inhibitor and amidine derivative salts, their preparation process, their use as medicaments, and pharmaceutical compositions containing them
ZA964097B (en) New variant of apolipoprotein a-i
AU694292B2 (en) Process for deactivating or destroying microorganisms
AU4623396A (en) 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
MX9701816A (es) Cepas de bacterias y composicion farmaceutica que contiene dichas cepas y uso de la misma para prevenir y tratar enfermedades asociadas con el metabolismo alterado de acidos biliares o causadas por el mismo.
GB9515279D0 (en) Improved therapeutic agents
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
CA2098842A1 (en) Use of host cell phospholipids for inhibiting microbial colonization
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
AU3166295A (en) Imidazopyridine-azolidinones
AU6700996A (en) Somatostatin-analogous cyclic peptides with inhibitory activity on growth hormone
AU1875395A (en) 4-amino derivatives of 5-substituted mycophenolic acid
BG101983A (en) Substituted phenylamidines, medicamentous forms containing them and mehtod for their preparation
DE59712297D1 (de) 3-alkylimidazopyridine
DE69814401D1 (de) 2,3-benzodiazepin-derivate
MX9800053A (es) Herbicidas de cis-2,3-expoxicicloalcanol bencilado.
GB9801913D0 (en) Protection against pathogenic microorganisms